5/30
04:50 pm
phge
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Medium
Report
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
5/30
07:00 am
phge
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
High
Report
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
5/21
06:40 am
phge
BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates [Yahoo! Finance]
Low
Report
BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates [Yahoo! Finance]
5/21
06:30 am
phge
BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates
Low
Report
BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates
5/15
07:00 am
phge
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
Low
Report
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
4/23
08:12 am
phge
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) [Yahoo! Finance]
High
Report
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) [Yahoo! Finance]
4/23
08:00 am
phge
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
High
Report
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
4/18
08:00 am
phge
BiomX Announces the Appointment of Susan Blum to its Board of Directors
Low
Report
BiomX Announces the Appointment of Susan Blum to its Board of Directors
4/4
09:57 am
phge
BiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
4/4
07:49 am
phge
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
Medium
Report
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
4/3
06:52 am
phge
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
4/3
06:30 am
phge
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/27
06:30 am
phge
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
Low
Report
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
3/19
05:12 am
phge
Telum Therapeutics appoints Dr. Subhendu Basu as CEO [Yahoo! Finance]
Medium
Report
Telum Therapeutics appoints Dr. Subhendu Basu as CEO [Yahoo! Finance]
3/19
05:00 am
phge
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
Medium
Report
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
3/19
05:00 am
phge
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
Medium
Report
Telum Therapeutics appoints Dr. Subhendu Basu as CEO